Biohaven Ltd. insider trading

BHVNNYSE

$11.88-0.20 (-1.66% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 7, 2025 to Oct 7, 2026. Price (-20.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25

Unlock quarterly net flow

Key players

JYJohn YetimogluDirector4.1379%of company
VCVlad CoricChief Executive Officer2.5485%of company
JWJohn W. ChildsDirector1.5871%of company
GBGregory BaileyDirector1.3374%of company
WKWarren Karl VollesChief Legal Officer0.1643%of company
MBMatthew ButenChief Financial Officer0.1295%of company
KGKimberly GentileSVP, Clinical Operations0.0659%of company
GCGeorge C. ClarkVP, Chief Accounting Officer0.0576%of company
BCBruce CarChief Scientific Officer0.025%of company
KMKishan MehtaDirector0.015%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
BHVN	George C. ClarkVP, Chief Accounting Officer	Open market purchase$145K	+24.8%	$8.52	$145K	Nov 17, 2025	Nov 18, 2025
BHVN	Gregory BaileyDirector	Open market purchase$3M	+24.7%	$7.50	$3M	Nov 13, 2025	Nov 17, 2025
BHVN	Vlad CoricChief Executive Officer	Open market purchase$2.5M	+9.5%	$7.50	$2.5M	Nov 13, 2025	Nov 17, 2025
BHVN	Vlad CoricChief Executive Officer	Open market purchase$2.5M	+9.5%	$7.50	$2.5M	Nov 13, 2025	Nov 17, 2025
BHVN	John W. ChildsDirector	Open market purchase$25M	+50.9%	$7.50	$25M	Nov 13, 2025	Nov 17, 2025

End of history · 5 transactions